APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

ADC Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global ADC Drug Industry Growth and Trends Forecast to 2032

Report ID 173960500122 December 202598 pages

Choose your research edition.

Industry ResearchADC Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal ADC Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADC Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal ADC Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global ADC Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of ADC Drug include RemeGen Co., Ltd., Roche, Gilead(Immunomedics), Pfizer Inc., AstraZeneca, Seagen, Rakuten Medical and ADC Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global ADC Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The ADC Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global ADC Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to ADC Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global ADC Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

ADC Drug Market by Company

RemeGen Co., Ltd.

Roche

Gilead(Immunomedics)

Pfizer Inc.

AstraZeneca

Seagen

Rakuten Medical

ADC Therapeutics

ADC Drug Segment by Type

First Generation ADC Drug

Third Generation ADC Drug

Second Generation ADC Drug

ADC Drug Segment by Application

Leukemia

Lymphoma

Breast Cancer

Other

ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ADC Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Generation ADC Drug Table 2. Major Company of Third Generation ADC Drug Table 3. Major Company of Second Generation ADC Drug Table 4. Global ADC Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global ADC Drug Sales by Type (2021-2026) & (k units) Table 6. Global ADC Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global ADC Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global ADC Drug Price by Type (2021-2026) & (US$/unit) Table 10. Global ADC Drug Sales by Type (2027-2032) & (k units) Table 11. Global ADC Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global ADC Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global ADC Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global ADC Drug Price by Type (2027-2032) & (US$/unit) Table 15. North America ADC Drug Sales by Type (2021-2026) & (k units) Table 16. North America ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe ADC Drug Sales by Type (2021-2026) & (k units) Table 18. Europe ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific ADC Drug Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America ADC Drug Sales by Type (2021-2026) & (k units) Table 22. Latin America ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa ADC Drug Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 25. ADC Drug Industry Trends Table 26. ADC Drug Industry Drivers Table 27. ADC Drug Industry Opportunities and Challenges Table 28. ADC Drug Industry Restraints Table 29. Global ADC Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global ADC Drug Revenue Market Share by Company (2021-2026) Table 31. Global ADC Drug Sales by Company (2021-2026) & (k units) Table 32. Global ADC Drug Sales Share by Company (2021-2026) Table 33. Global ADC Drug Market Price by Company (2021-2026) & (US$/unit) Table 34. Global ADC Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global ADC Drug Major Company Production Sites and Headquarters Table 36. Global ADC Drug Company, Product Type & Application Table 37. Global ADC Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global ADC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global ADC Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global ADC Drug Sales by Region (2021-2026) & (k units) Table 42. Global ADC Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global ADC Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global ADC Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global ADC Drug Sales by Region (2027-2032) & (k units) Table 47. Global ADC Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global ADC Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global ADC Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global ADC Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global ADC Drug Sales by Application (2021-2026) & (k units) Table 53. Global ADC Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global ADC Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global ADC Drug Price by Application (2021-2026) & (US$/unit) Table 57. Global ADC Drug Sales by Application (2027-2032) & (k units) Table 58. Global ADC Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global ADC Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global ADC Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global ADC Drug Price by Application (2027-2032) & (US$/unit) Table 62. North America ADC Drug Sales by Application (2021-2026) & (k units) Table 63. North America ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe ADC Drug Sales by Application (2021-2026) & (k units) Table 65. Europe ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific ADC Drug Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America ADC Drug Sales by Application (2021-2026) & (k units) Table 69. Latin America ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa ADC Drug Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 72. RemeGen Co., Ltd. Company Information Table 73. RemeGen Co., Ltd. Business Overview Table 74. RemeGen Co., Ltd. ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. RemeGen Co., Ltd. ADC Drug Product Portfolio Table 76. RemeGen Co., Ltd. Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Roche ADC Drug Product Portfolio Table 81. Roche Recent Development Table 82. Gilead(Immunomedics) Company Information Table 83. Gilead(Immunomedics) Business Overview Table 84. Gilead(Immunomedics) ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Gilead(Immunomedics) ADC Drug Product Portfolio Table 86. Gilead(Immunomedics) Recent Development Table 87. Pfizer Inc. Company Information Table 88. Pfizer Inc. Business Overview Table 89. Pfizer Inc. ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer Inc. ADC Drug Product Portfolio Table 91. Pfizer Inc. Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. AstraZeneca ADC Drug Product Portfolio Table 96. AstraZeneca Recent Development Table 97. Seagen Company Information Table 98. Seagen Business Overview Table 99. Seagen ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Seagen ADC Drug Product Portfolio Table 101. Seagen Recent Development Table 102. Rakuten Medical Company Information Table 103. Rakuten Medical Business Overview Table 104. Rakuten Medical ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Rakuten Medical ADC Drug Product Portfolio Table 106. Rakuten Medical Recent Development Table 107. ADC Therapeutics Company Information Table 108. ADC Therapeutics Business Overview Table 109. ADC Therapeutics ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. ADC Therapeutics ADC Drug Product Portfolio Table 111. ADC Therapeutics Recent Development Table 112. North America ADC Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America ADC Drug Sales by Country (2021-2026) & (k units) Table 114. North America ADC Drug Sales Market Share by Country (2021-2026) Table 115. North America ADC Drug Sales Forecast by Country (2027-2032) & (k units) Table 116. North America ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 117. North America ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 119. North America ADC Drug Market Share by Country (2021-2026) Table 120. North America ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America ADC Drug Market Share Forecast by Country (2027-2032) Table 122. Europe ADC Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe ADC Drug Sales by Country (2021-2026) & (k units) Table 124. Europe ADC Drug Sales Market Share by Country (2021-2026) Table 125. Europe ADC Drug Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 127. Europe ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe ADC Drug Market Share by Country (2021-2026) Table 130. Europe ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe ADC Drug Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific ADC Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific ADC Drug Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific ADC Drug Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific ADC Drug Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific ADC Drug Market Share by Country (2021-2026) Table 140. Asia-Pacific ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific ADC Drug Market Share Forecast by Country (2027-2032) Table 142. Latin America ADC Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America ADC Drug Sales by Country (2021-2026) & (k units) Table 144. Latin America ADC Drug Sales Market Share by Country (2021-2026) Table 145. Latin America ADC Drug Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America ADC Drug Market Share by Country (2021-2026) Table 150. Latin America ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America ADC Drug Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa ADC Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa ADC Drug Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa ADC Drug Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa ADC Drug Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa ADC Drug Market Share by Country (2021-2026) Table 160. Middle East and Africa ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa ADC Drug Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. ADC Drug Distributors List Table 165. ADC Drug Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. ADC Drug Image Figure 2. Global ADC Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ADC Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global ADC Drug Sales (2021-2032) & (k units) Figure 5. First Generation ADC Drug Image Figure 6. Global First Generation ADC Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Third Generation ADC Drug Image Figure 8. Global Third Generation ADC Drug Sales YoY Growth (2021-2032) & (k units) Figure 9. Second Generation ADC Drug Image Figure 10. Global Second Generation ADC Drug Sales YoY Growth (2021-2032) & (k units) Figure 11. Global ADC Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global ADC Drug Market Share by Type 2025 VS 2032 Figure 13. North America ADC Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America ADC Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe ADC Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe ADC Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific ADC Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific ADC Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America ADC Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America ADC Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa ADC Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa ADC Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 ADC Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Leukemia Image Figure 26. Global Leukemia Sales YoY Growth (2021-2032) & (k units) Figure 27. Lymphoma Image Figure 28. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 29. Breast Cancer Image Figure 30. Global Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global ADC Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global ADC Drug Market Share by Application 2025 VS 2032 Figure 35. North America ADC Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America ADC Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe ADC Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe ADC Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific ADC Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific ADC Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America ADC Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America ADC Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa ADC Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa ADC Drug Sales Market Share in Value by Application in 2025 Figure 45. North America ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. ADC Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. ADC Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation ADC Drug
  • Third Generation ADC Drug
  • Second Generation ADC Drug
Applications
  • Leukemia
  • Lymphoma
  • Breast Cancer
  • Other
Companies covered
  • RemeGen Co., Ltd.
  • Roche
  • Gilead(Immunomedics)
  • Pfizer Inc.
  • AstraZeneca
  • Seagen
  • Rakuten Medical
  • ADC Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global ADC Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global ADC Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 ADC Drug Market by Type
  6. 1.3.1 First Generation ADC Drug
  7. 1.3.2 Third Generation ADC Drug
  8. 1.3.3 Second Generation ADC Drug
  9. 1.4 Global ADC Drug Market Size by Type
  10. 1.4.1 Global ADC Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global ADC Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global ADC Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America ADC Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe ADC Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific ADC Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America ADC Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa ADC Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 ADC Drug Industry Trends
  2. 2.2 ADC Drug Industry Drivers
  3. 2.3 ADC Drug Industry Opportunities and Challenges
  4. 2.4 ADC Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by ADC Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by ADC Drug Sales (2021-2026)
  3. 3.3 Global Top Players by ADC Drug Price (2021-2026)
  4. 3.4 Global ADC Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global ADC Drug Major Company Production Sites & Headquarters
  6. 3.6 Global ADC Drug Company, Product Type & Application
  7. 3.7 Global ADC Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global ADC Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 ADC Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 ADC Drug Tier 1, Tier 2, and Tier 3
4 ADC Drug Regional Status and Outlook
  1. 4.1 Global ADC Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global ADC Drug Historic Market Size by Region
  3. 4.2.1 Global ADC Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global ADC Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global ADC Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global ADC Drug Forecasted Market Size by Region
  7. 4.3.1 Global ADC Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global ADC Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global ADC Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 ADC Drug by Application
  1. 5.1 ADC Drug Market by Application
  2. 5.1.1 Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Other
  6. 5.2 Global ADC Drug Market Size by Application
  7. 5.2.1 Global ADC Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global ADC Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global ADC Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America ADC Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe ADC Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific ADC Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America ADC Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa ADC Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 RemeGen Co., Ltd.
  2. 6.1.1 RemeGen Co., Ltd. Company Information
  3. 6.1.2 RemeGen Co., Ltd. Business Overview
  4. 6.1.3 RemeGen Co., Ltd. ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 RemeGen Co., Ltd. ADC Drug Product Portfolio
  6. 6.1.5 RemeGen Co., Ltd. Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche ADC Drug Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Gilead(Immunomedics)
  14. 6.3.1 Gilead(Immunomedics) Company Information
  15. 6.3.2 Gilead(Immunomedics) Business Overview
  16. 6.3.3 Gilead(Immunomedics) ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Gilead(Immunomedics) ADC Drug Product Portfolio
  18. 6.3.5 Gilead(Immunomedics) Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc. ADC Drug Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca ADC Drug Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Seagen
  32. 6.6.1 Seagen Company Information
  33. 6.6.2 Seagen Business Overview
  34. 6.6.3 Seagen ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Seagen ADC Drug Product Portfolio
  36. 6.6.5 Seagen Recent Developments
  37. 6.7 Rakuten Medical
  38. 6.7.1 Rakuten Medical Company Information
  39. 6.7.2 Rakuten Medical Business Overview
  40. 6.7.3 Rakuten Medical ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rakuten Medical ADC Drug Product Portfolio
  42. 6.7.5 Rakuten Medical Recent Developments
  43. 6.8 ADC Therapeutics
  44. 6.8.1 ADC Therapeutics Company Information
  45. 6.8.2 ADC Therapeutics Business Overview
  46. 6.8.3 ADC Therapeutics ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ADC Therapeutics ADC Drug Product Portfolio
  48. 6.8.5 ADC Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America ADC Drug Sales by Country
  2. 7.1.1 North America ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America ADC Drug Sales by Country (2021-2026)
  4. 7.1.3 North America ADC Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America ADC Drug Market Size by Country
  6. 7.2.1 North America ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America ADC Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America ADC Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe ADC Drug Sales by Country
  2. 8.1.1 Europe ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe ADC Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe ADC Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe ADC Drug Market Size by Country
  6. 8.2.1 Europe ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe ADC Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe ADC Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific ADC Drug Sales by Country
  2. 9.1.1 Asia-Pacific ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific ADC Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific ADC Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific ADC Drug Market Size by Country
  6. 9.2.1 Asia-Pacific ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific ADC Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific ADC Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America ADC Drug Sales by Country
  2. 10.1.1 South America ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America ADC Drug Sales by Country (2021-2026)
  4. 10.1.3 South America ADC Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America ADC Drug Market Size by Country
  6. 10.2.1 South America ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America ADC Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America ADC Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa ADC Drug Sales by Country
  2. 11.1.1 Middle East and Africa ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa ADC Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa ADC Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa ADC Drug Market Size by Country
  6. 11.2.1 Middle East and Africa ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa ADC Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa ADC Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 ADC Drug Value Chain Analysis
  2. 12.1.1 ADC Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 ADC Drug Production Mode & Process
  7. 12.2 ADC Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 ADC Drug Distributors
  10. 12.2.3 ADC Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst